Medco, AssureRx Team on PGx Study of Psychotropic Medications | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Medco Research Institute and AssureRx today said that they have teamed up to initiate the PREDICT PSYMEDS (Pharmacogenetic-Directed Prescribing of Psychotropic Medications) pilot to evaluate psychotropic drug adherence and medical care utilization among Medco members after they've been genotyped.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.